手术切除是目前治愈原发性肝癌(HCC)的唯一途径,但由于本病早期缺乏症状,以致确定诊断时,疾病常届中晚期,失去手术切除的机会。全身化疗、肝动脉结扎或插管化疗和放射治疗,均曾应用于不能手术治疗的病例,但疗效均不满意,自从1975年日本Yamata等应用动脉插管栓塞疗法(TAE),1982年Konno等应用碘化油作为载体和栓塞剂,进行化学栓 Surgical resection is currently the only way to cure primary hepatocellular carcinoma (HCC), but due to the lack of symptoms in the early stage of the disease, when the diagnosis is made, the disease is usually in the middle and late stages, and the chance of surgical resection is lost. Systemic chemotherapy, hepatic artery ligation, or intubation chemotherapy and radiation therapy have all been used in cases that cannot be treated, but the efficacy is not satisfactory. Since 1975 Japan Yamata et al. used arterial intubation embolization (TAE), 1982 Konno et al. Use iodized oil as carrier and embolic agent for chemical thrombosis